Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Chronic Progressive

Explore clinical trials studying Multiple Sclerosis, Chronic Progressive. Study availability and eligibility vary by location and protocol.

186 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Chronic Progressive trial results

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

NCT04544449

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Alabama Neurology Associates Homewood, Alabama, United States
  • Sutter East Bay Medical Foundation Berkeley, California, United States
  • Fullerton Neurology and Headache Center Fullerton, California, United States
  • Palo Alto Medical Foundation Research Center Sunnyvale, California, United States
View all 190 locations
View Trial Details
Active, not recruiting

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

NCT04695080

Conditions
Advanced Multiple Sclerosis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +12 more
Locations
  • Queens University Belfast (Belfast Health and Social Care Trust) Belfast, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham Birmingham, United Kingdom
  • Cardiff University Hospital Cardiff, United Kingdom
  • University Hospitals of Coventry and Warwickshire NHS Trust Coventry, United Kingdom
View all 22 locations
View Trial Details
Active, not recruiting

Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)

NCT06675864

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Québec, Quebec, Canada
  • Novartis Investigative Site Bron, France
View all 18 locations
View Trial Details
Active, not recruiting

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

NCT04688788

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • Danish Multiple Sclerosis Center, Rigshospitalet Glostrup Municipality, Copenhagen, Denmark
  • Department of Neurology, Aalborg University Hospital Aalborg, Denmark
  • Department of Neurology, Aarhus University Hospital Aarhus, Denmark
  • Department of Neurology, Hospital of South West Jutland, Esbjerg Esbjerg, Denmark
View Trial Details

Related conditions